期刊
CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS
卷 9, 期 5, 页码 368-376出版社
SPRINGER
DOI: 10.1007/s11910-009-0054-1
关键词
-
资金
- NIA NIH HHS [P50 AG005138] Funding Source: Medline
With the aging of the population, the incidence and prevalence of Alzheimer's disease will grow, increasing the burden on individuals and society. While ameliorating symptoms, the currently available treatments approved by the US Food and Drug Administration do not halt progression or cure the illness. This article discusses recent data on treatment strategies targeting amyloid and tau pathology. Novel therapeutic strategies such as inhibitors of receptors for advanced glycation end products (RAGE), potential mitochondrial modification with Dimebon, anti-inflammatory approaches, and cholesterol-lowering agents are also reviewed. An update on results from pharmacologic and nonpharmacologic prevention trials is provided.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据